Srs Capital Advisors, Inc. First Trust Nyse Arca Biotechn Transaction History

Srs Capital Advisors, Inc.

$1.48 Billion
Q1 2025

A detailed history of Srs Capital Advisors, Inc. transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 5,477 shares of FBT stock, worth $883,330. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,477

Previous 3,931 39.33%

Holding current value

$883,330

Previous $653,000 42.57%

% of portfolio

0.06%

Previous 0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$164.86 - $182.19 $254,873 - $281,665	1,546 Added 39.33%	5,477 $931,000
Q4 2024 Feb 05, 2025	BUY	$161.65 - $178.69 $46,231 - $51,105	286 Added 7.85%	3,931 $653,000
Q3 2024 Nov 06, 2024	BUY	$152.39 - $172.91 $74,975 - $85,071	492 Added 15.6%	3,645 $626,000
Q2 2024 Aug 06, 2024	BUY	$141.52 - $156.4 $30,568 - $33,782	216 Added 7.35%	3,153 $485,000
Q1 2024 May 14, 2024	BUY	$145.08 - $160.46 $208,334 - $230,420	1,436 Added 95.67%	2,937 $451,000
Q4 2023 Feb 06, 2024	BUY	$132.5 - $158.45 $144,822 - $173,185	1,093 Added 267.89%	1,501 $237,000
Q3 2023 Nov 14, 2023	BUY	$145.69 - $157.89 $28,118 - $30,472	193 Added 89.77%	408 $59,000
Q2 2023 Aug 14, 2023	BUY	$151.19 - $159.79 $8,013 - $8,468	53 Added 32.72%	215 $32,000
Q1 2023 May 16, 2023	BUY	$147.92 - $165.37 $21,744 - $24,309	147 Added 980.0%	162 $25,000
Q3 2022 Nov 03, 2022	BUY	$128.6 - $149.75 $1,929 - $2,246	15 New	15 $2,000

Others Institutions Holding FBT

# of Institutions

297

Shares Held

3.78M

Call Options Held

14K

Put Options Held

200

View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

More about FBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. First Trust Nyse Arca Biotechn Transaction History